Malegra DXT: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation
Malegra DXT
| Product dosage: 130mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.77 | $53.00 (0%) | 🛒 Add to cart |
| 60 | $1.42 | $106.00 $85.00 (20%) | 🛒 Add to cart |
| 90 | $1.30 | $159.00 $117.00 (26%) | 🛒 Add to cart |
| 120 | $1.24 | $212.00 $149.00 (30%) | 🛒 Add to cart |
| 180 | $1.19 | $318.00 $214.00 (33%) | 🛒 Add to cart |
| 270 | $1.15
Best per pill | $477.00 $310.00 (35%) | 🛒 Add to cart |
Similar products
Malegra DXT is a specialized, dual-action pharmaceutical formulation designed to address two of the most prevalent male sexual health concerns concurrently: erectile dysfunction (ED) and premature ejaculation (PE). It combines two well-established active ingredients, Sildenafil Citrate and Dapoxetine, into a single tablet, offering a comprehensive therapeutic approach. This medication is engineered to provide reliable erectile support while significantly extending intravaginal ejaculatory latency time, thereby improving sexual performance and satisfaction. It is indicated for adult men experiencing both conditions and should be used under appropriate medical supervision following a thorough clinical assessment.
Features
- Contains Sildenafil Citrate (100mg) and Dapoxetine (60mg) in a fixed-dose combination
- Formulated as film-coated tablets for ease of ingestion
- Rapid onset of action; typically effective within 30-60 minutes post-administration
- Designed for on-demand use prior to anticipated sexual activity
- Manufactured under strict quality control standards in GMP-certified facilities
Benefits
- Achieves and maintains firm erections sufficient for satisfactory sexual intercourse
- Significantly delays ejaculation, enhancing control over ejaculatory timing
- Improves sexual confidence and reduces performance-related anxiety
- Addresses both physiological and psychological aspects of sexual dysfunction
- Convenient single-tablet regimen simplifies treatment compared to multiple medications
- May improve overall sexual satisfaction for both partners
Common use
Malegra DXT is clinically indicated for the treatment of men who experience both erectile dysfunction and premature ejaculation. It is prescribed for adult males who have been properly diagnosed with these concurrent conditions by a healthcare professional. The medication is intended for on-demand use rather than continuous daily administration. It should be taken approximately 1-3 hours before anticipated sexual activity, as both components require time to reach therapeutic concentrations in the bloodstream. Sexual stimulation is necessary for the erectile response component to be effective.
Dosage and direction
The recommended dosage is one tablet taken orally with a full glass of water, approximately 1-3 hours before sexual activity. Do not exceed one tablet within a 24-hour period. The tablet should be swallowed whole and not crushed, chewed, or broken. Administration with a high-fat meal may delay the onset of action of both active ingredients. The medication should not be taken more frequently than once daily. Healthcare providers may adjust the dosing recommendations based on individual patient response and tolerance.
Precautions
Patients should undergo a thorough medical evaluation before initiating treatment with Malegra DXT. Cardiovascular status should be assessed, as sexual activity carries potential cardiac risk. Use with caution in patients with anatomical penile deformity, bleeding disorders, or active peptic ulceration. Avoid alcohol consumption while taking this medication, as it may increase the risk of adverse effects including dizziness, hypotension, and syncope. Patients should be advised not to engage in activities requiring alertness (such as driving or operating machinery) until they know how the medication affects them.
Contraindications
Malegra DXT is contraindicated in patients with known hypersensitivity to Sildenafil Citrate, Dapoxetine, or any excipients in the formulation. Concurrent administration with nitrates or nitric oxide donors is absolutely contraindicated due to the risk of profound hypotension. It is contraindicated in patients with severe hepatic impairment, severe cardiovascular disorders, unstable angina, recent myocardial infarction, or history of stroke. Concomitant use with potent CYP3A4 inhibitors, monoamine oxidase inhibitors (MAOIs), thioridazine, or serotonin reuptake inhibitors other than Dapoxetine is contraindicated.
Possible side effects
Common side effects may include headache, flushing, dizziness, nausea, dry mouth, insomnia, and nasal congestion. Visual disturbances (including blurred vision, color tinge, and increased light sensitivity) may occur due to phosphodiesterase inhibition. Orthostatic hypotension, palpitations, and tachycardia have been reported. Gastrointestinal effects such as diarrhea or constipation may occur. Rare but serious adverse effects include priapism (prolonged erection lasting more than 4 hours), syncope, serotonin syndrome (especially when combined with other serotonergic drugs), and sudden hearing loss. Patients experiencing any severe or persistent side effects should seek immediate medical attention.
Drug interaction
Malegra DXT has significant interaction potential. Concomitant use with nitrates, alpha-blockers, antihypertensives, or other vasodilators may potentiate hypotensive effects. Strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) and CYP2D6 inhibitors may increase plasma concentrations of the active components. Concurrent use with other phosphodiesterase inhibitors is not recommended. Serotonergic drugs (including SSRIs, SNRIs, tricyclic antidepressants, tramadol, and triptans) may increase the risk of serotonin syndrome. Grapefruit juice may increase Sildenafil concentrations and should be avoided.
Missed dose
As Malegra DXT is taken on an as-needed basis rather than on a scheduled regimen, the concept of a “missed dose” does not typically apply. If a patient forgets to take the medication before sexual activity, they should not take a double dose later. Instead, they should take a single tablet at the appropriate time before their next anticipated sexual activity, ensuring at least 24 hours have passed since any previous dose. Patients should not exceed one tablet in any 24-hour period.
Overdose
In case of suspected overdose, immediate medical attention should be sought. Symptoms may include severe headache, dizziness, syncope, prolonged erection, severe hypotension, tachycardia, and serotonin syndrome manifestations. Treatment is supportive and symptomatic. Priapism requires immediate urological intervention to prevent permanent tissue damage. Hemodialysis is not expected to significantly enhance elimination of either component due to high protein binding. Cardiovascular monitoring is essential in cases of significant overdose.
Storage
Store at room temperature (15-30°C or 59-86°F) in the original packaging to protect from light and moisture. Keep the container tightly closed and out of reach of children and pets. Do not use after the expiration date printed on the packaging. Do not transfer tablets to other containers, as this may expose them to moisture and reduce stability. Properly dispose of any unused or expired medication according to local regulations, preferably through medication take-back programs.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Malegra DXT is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary, and not all patients will experience the described benefits. Patients should disclose their complete medical history and current medications to their healthcare provider before using this product. The manufacturer is not responsible for misuse or inappropriate administration of this medication.
Reviews
Clinical studies have demonstrated that the combination of Sildenafil Citrate and Dapoxetine provides significant improvement in both erectile function and ejaculatory control compared to placebo. Patients report improved sexual satisfaction, increased confidence, and enhanced relationship quality. Many users appreciate the convenience of a single tablet addressing both conditions. Some patients report side effects that may affect treatment continuation, particularly during the initial adjustment period. Healthcare providers generally consider this combination therapy effective for appropriate candidates who have been properly screened for contraindications.